Characteristics of histamine release from cultured human mast cells. 1996

Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
Department of Dermatology, Gunma University School of Medicine, Maebashi, Japan.

BACKGROUND The mast cell is one of the important cells in the pathogenesis of allergic disorders. However, isolating human mast cells is a laborious procedure. Recently, cultured human mast cells raised from umbilical cord blood cells have become available. It is necessary to examine whether these cells are useful in investigating the role of mast cells in human diseases. OBJECTIVE The phenotype of mast cells depends on their anatomical sites. To examine which phenotype of mast cells these cultured mast cells most closely resemble, their ability to release was investigated. METHODS The mast cells were raised from human umbilical cord blood cells in the presence of stem cell factor and interleukin-6. To determine the mast cell subtypes, the mast cells were immunocytochemically stained for tryptase and chymase. The cultured mast cells were then stimulated with various secretagogues, and histamine release was measured by a fluorometric technique using high-performance liquid chromatography. RESULTS The immunocytochemical staining for mast cell proteases revealed that virtually all cells contained tryptase, the definitive marker of mast cells, and that about a quarter of the cells contained chymase. Anti-IgE effectively stimulated these mast cells to release histamine in a dose-dependent, time-dependent manner. The release was completed in about 30 min. One of the non-specific stimuli, calcium ionophore A23187, also induced histamine release in a dose-dependent, time-dependent manner. In contrast, compound 48/80 and substance P failed to induce histamine release from these cells. CONCLUSIONS Cultured human mast cells resemble lung mast cells in their ability to release histamine. They will help in studying the functional properties of human mast cells and may contribute to clarifying the pathophysiology of human allergic diseases.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000001 Calcimycin An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-,A-23187,A23187,Antibiotic A23187,A 23187,A23187, Antibiotic
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
April 1982, Agents and actions,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
May 1997, The Journal of pharmacy and pharmacology,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
August 1984, The Journal of allergy and clinical immunology,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
April 2007, International immunopharmacology,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
January 1998, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
December 2002, Cytokine,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
April 1983, Journal of immunology (Baltimore, Md. : 1950),
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
January 1963, Surgical forum,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
January 1988, Archives of dermatological research,
Y Igarashi, and M Kurosawa, and O Ishikawa, and Y Miyachi, and H Saito, and M Ebisawa, and Y Iikura, and M Yanagida, and H Uzumaki, and T Nakahata
January 1989, Advances in experimental medicine and biology,
Copied contents to your clipboard!